Inhibition of RANKL is critical for accurate assessment of anti-drug antibody incidence to denosumab in clinical studies.
- DOI
- 10.1016/j.jim.2025.113864
- Published
- 2025 May
- Container
- Journal of immunological methods
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jim.2025.113864,
title = {Inhibition of RANKL is critical for accurate assessment of anti-drug antibody incidence to denosumab in clinical studies.},
author = {Miller MJ and Kroenke MA and Barger T and Manning MS and Sohn W and Graham K and Mytych DT and Gupta S},
year = {2025},
journal = {Journal of immunological methods},
doi = {10.1016/j.jim.2025.113864},
url = {https://doi.org/10.1016/j.jim.2025.113864}
}RIS
TY - JOUR TI - Inhibition of RANKL is critical for accurate assessment of anti-drug antibody incidence to denosumab in clinical studies. AU - Miller MJ AU - Kroenke MA AU - Barger T AU - Manning MS AU - Sohn W AU - Graham K AU - Mytych DT AU - Gupta S PY - 2025 JO - Journal of immunological methods DO - 10.1016/j.jim.2025.113864 UR - https://doi.org/10.1016/j.jim.2025.113864 ER -
APA
MJ, M., MA, K., T, B., MS, M., W, S., K, G., DT, M., & S, G. (2025). Inhibition of RANKL is critical for accurate assessment of anti-drug antibody incidence to denosumab in clinical studies.. Journal of immunological methods. https://doi.org/10.1016/j.jim.2025.113864
Source records
- pubmed · retrieved 2026-11-10T11:29:41.145Z
- europe-pmc · retrieved 2026-11-10T11:29:41.159Z